Literature DB >> 19704398

Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics.

Charlotte Gaydos1, Nancy E Maldeis, Andrew Hardick, Justin Hardick, Thomas C Quinn.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium, in women attending a sexually transmitted disease (STD) clinic, as well as the frequency of coinfections, and relationship of each organism to cervicitis.
METHODS: In this cross-sectional study of 324 women attending Baltimore City STD Clinics, C. trachomatis, N. gonorrhoeae, T. vaginalis, and M. genitalium were detected using nucleic acid amplification tests. Demographic characteristics and risk factors were ascertained.
RESULTS: Overall prevalence of infection with C. trachomatis, N. gonorrhoeae, T. vaginalis, and M. genitalium was found to be 11.1%, 4.6%, 15.3%, and 19.2%, respectively. Prevalence in women with cervicitis was 15.8%, 6%, 18.9%, and 28.6% for C. trachomatis, N. gonorrhoeae, T. vaginalis, and M. genitalium, respectively. Percentages of coinfections were high. C. trachomatis and M. genitalium were significantly associated with cervicitis in univariate analysis, but only M. genitalium was significantly associated with cervicitis (AOR: 2.5) in multiple logistic regression models.
CONCLUSION: Knowledge of the statistical association of M. genitalium with cervicitis in this study increases the need for further confirmation of the etiologic significance of this organism with cervicitis in more diverse populations. The high prevalence merits more study and may have implications for diagnosis and treatment of cervicitis.

Entities:  

Mesh:

Year:  2009        PMID: 19704398      PMCID: PMC2924808          DOI: 10.1097/OLQ.0b013e3181b01948

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  43 in total

1.  Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy.

Authors:  J M Marrazzo; C L Celum; S D Hillis; D Fine; S DeLisle; H H Handsfield
Journal:  Sex Transm Dis       Date:  1997-03       Impact factor: 2.830

Review 2.  Association of sexually transmitted diseases and infection with the human immunodeficiency virus: biological cofactors and markers of behavioural interventions.

Authors:  T C Quinn
Journal:  Int J STD AIDS       Date:  1996       Impact factor: 1.359

3.  Mycoplasma genitalium in the cervices of Japanese women.

Authors:  M Uno; T Deguchi; H Komeda; M Hayasaki; M Iida; M Nagatani; Y Kawada
Journal:  Sex Transm Dis       Date:  1997-05       Impact factor: 2.830

4.  Randomized treatment of mucopurulent cervicitis with doxycycline or amoxicillin.

Authors:  J Paavonen; P L Roberts; C E Stevens; P Wølner-Hanssen; R C Brunham; S Hillier; W E Stamm; C C Kuo; T DeRouen; K K Holmes
Journal:  Am J Obstet Gynecol       Date:  1989-07       Impact factor: 8.661

5.  Bacterial vaginosis as a risk factor for upper genital tract infection.

Authors:  J F Peipert; A B Montagno; A S Cooper; C J Sung
Journal:  Am J Obstet Gynecol       Date:  1997-11       Impact factor: 8.661

6.  Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men.

Authors:  R C Brunham; J Paavonen; C E Stevens; N Kiviat; C C Kuo; C W Critchlow; K K Holmes
Journal:  N Engl J Med       Date:  1984-07-05       Impact factor: 91.245

7.  High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin.

Authors:  Michael J Schlicht; Steven D Lovrich; Jeffrey S Sartin; Patricia Karpinsky; Steven M Callister; William A Agger
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Mucopurulent cervicitis: a clinical entity?

Authors:  F E Willmott
Journal:  Genitourin Med       Date:  1988-06

9.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

10.  Etiology of cervical inflammation.

Authors:  J Paavonen; C W Critchlow; T DeRouen; C E Stevens; N Kiviat; R C Brunham; W E Stamm; C C Kuo; K E Hyde; L Corey
Journal:  Am J Obstet Gynecol       Date:  1986-03       Impact factor: 8.661

View more
  50 in total

1.  Diversity of cervicovaginal microbiota associated with female lower genital tract infections.

Authors:  Zongxin Ling; Xia Liu; Xiaoyi Chen; Haibin Zhu; Karen E Nelson; Yaxian Xia; Lanjuan Li; Charlie Xiang
Journal:  Microb Ecol       Date:  2011-02-02       Impact factor: 4.552

2.  Cervicitis of unknown etiology.

Authors:  Stephanie N Taylor
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

3.  Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.

Authors:  Kaitlin A Tagg; Neisha J Jeoffreys; Deborah L Couldwell; Jennifer A Donald; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

5.  Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens.

Authors:  Patricia M Dehon; Chris L McGowin
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

6.  Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women.

Authors:  Emily B Hancock; Lisa E Manhart; Sara J Nelson; Roxanne Kerani; Jennifer K H Wroblewski; Patricia A Totten
Journal:  Sex Transm Dis       Date:  2010-12       Impact factor: 2.830

7.  Prevalence and treatment outcome of cervicitis of unknown etiology.

Authors:  Stephanie N Taylor; Shelly Lensing; Jane Schwebke; Rebecca Lillis; Leandro A Mena; Anita L Nelson; Anne Rinaldi; Lisa Saylor; Linda McNeil; Jeannette Y Lee
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

8.  Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors.

Authors:  Victoria L Mobley; Marcia M Hobbs; Karen Lau; Barbara S Weinbaum; Damon K Getman; Arlene C Seña
Journal:  Sex Transm Dis       Date:  2012-09       Impact factor: 2.830

9.  Clinical Laboratory Assessment of Mycoplasma genitalium Transcription-Mediated Amplification Using Primary Female Urogenital Specimens.

Authors:  Erik Munson; Holly Bykowski; Kimber L Munson; Maureen Napierala; Pamela J Reiss; Ronald F Schell; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

Review 10.  Mycoplasma, Ureaplasma, and adverse pregnancy outcomes: a fresh look.

Authors:  Bryan Larsen; Joseph Hwang
Journal:  Infect Dis Obstet Gynecol       Date:  2010-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.